The stock of Heron Therapeutics Inc. (HRTX) has gone up by 5.56% for the week, with a -50.00% drop in the past month and a -50.74% drop in the past quarter. The volatility ratio for the week is 13.65%, and the volatility levels for the past 30 days are 11.74% for HRTX. The simple moving average for the past 20 days is -34.35% for HRTX’s stock, with a -56.81% simple moving average for the past 200 days.
Is It Worth Investing in Heron Therapeutics Inc. (NASDAQ: HRTX) Right Now?
compared to its average ratio and a 36-month beta value of 0.97. Analysts have mixed views on the stock, with 6 analysts rating it as a “buy,” 0 as “overweight,” 0 as “hold,” and 0 as “sell.”
Unlock the Hottest Top 10 Penny Stocks Today! Discover Now
Dive into the world of lucrative penny stocks with MarketClub's groundbreaking "Smart Scan" technology! Get an instant snapshot of the top 50 high volume stocks with a clear direction and outstanding liquidity - in other words, the strongest trending. To unlock this exclusive list, simply provide your first name, last name, and email for instant access.
Gain Access to Top 10 Penny Stocks Now!.
Sponsored
The average price point forecasted by analysts for Heron Therapeutics Inc. (HRTX) is $7.92, which is $6.59 above the current market price. The public float for HRTX is 118.62M, and currently, short sellers hold a 18.80% ratio of that float. The average trading volume of HRTX on May 24, 2023 was 2.49M shares.
HRTX) stock’s latest price update
Heron Therapeutics Inc. (NASDAQ: HRTX)’s stock price has dropped by -8.28 in relation to previous closing price of 1.45. Nevertheless, the company has seen a gain of 5.56% in its stock price over the last five trading days.
HRTX Trading at -38.41% from the 50-Day Moving Average
After a stumble in the market that brought HRTX to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -76.33% of loss for the given period.
Volatility was left at 11.74%, however, over the last 30 days, the volatility rate increased by 13.65%, as shares sank -47.22% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -44.58% lower at present.
During the last 5 trading sessions, HRTX rose by +5.56%, which changed the moving average for the period of 200-days by -58.70% in comparison to the 20-day moving average, which settled at $1.9665. In addition, Heron Therapeutics Inc. saw -46.80% in overturn over a single year, with a tendency to cut further losses.
Stock Fundamentals for HRTX
Current profitability levels for the company are sitting at:
- -157.20 for the present operating margin
- +49.04 for the gross margin
The net margin for Heron Therapeutics Inc. stands at -169.05.
The liquidity ratio also appears to be rather interesting for investors as it stands at 2.49.
Conclusion
To put it simply, Heron Therapeutics Inc. (HRTX) has had a bad performance in recent times. Analysts have a bullish opinion on the stock, with some rating it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
